Skip to main content

Firmenich Names New VP of Ingredients

Julien Firmenich was appointed to the position, succeeding Amaury Roquette, who becomes vice president of sales and marketing for fine fragrance Europe.

PARIS — Julien Firmenich has been named vice president of ingredients at Swiss fragrance and flavors supplier Firmenich.

In the role, in which he succeeds Amaury Roquette, Firmenich is charged with focusing on innovation, creativity and long-term value creation, the company said Monday.

The executive will be based in Geneva and from July 1 report to Armand de Villoutreys, president of perfumery and ingredients.

Firmenich was most recently vice president of product strategy and promotion for the company’s ingredients branch, where he had a focus on product life cycle and innovation management. Prior to that he held positions within perfumery, such as fragrance development manager, and fine fragrance sales at the supplier.

“Julien’s experience in perfumery, cutting across body and home care and fine fragrance, as well as his leadership in ingredients, positions him well to drive our ingredients growth strategy with a focus on shaping unique olfactive experiences,” said Villoutreys.

Related Galleries

Roquette, for his part, was appointed vice president of sales and marketing for fine fragrance in Europe, also effective on July 1, based in Paris.

You May Also Like

Roquette joined Firmenich 10 years ago, starting in its strategy team. He then shifted his focus to ingredients.

“This new role gives me the opportunity to further my passion for ingredients and innovation as well as for the art of fine fragrance creation, to win with our customers,” the executive said in a statement.

Numerous executive changes have been afoot at Firmenich. In April it revealed, for instance, that Jerry Vittoria was named head of fine fragrances worldwide. In the role, the executive succeeded Oliver de Lisle, who retired.

In its most recent fiscal year, ended June 30, Firmenich reported 6.3 percent growth in sales to 3.2 billion Swiss francs, or $3.27 billion at average exchange, bolstered by strong research. In local currencies, the company’s revenues gained 8.2 percent in the 12-month period.